AXL drives immunotherapy resistance by modulating IL-17 in bladder cancer

Wenlong Wan, Fang Wei, Lu Yang, Xiao Yu, Ziqi Wang, Jianping Miao, Ben Zhao

Open source

DOI: 10.1016/j.bcp.2026.118486
Published: 2026-12
Container: Biochemical Pharmacology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.bcp.2026.118486,
  title = {AXL drives immunotherapy resistance by modulating IL-17 in bladder cancer},
  author = {Wenlong Wan and Fang Wei and Lu Yang and Xiao Yu and Ziqi Wang and Jianping Miao and Ben Zhao},
  year = {2026},
  journal = {Biochemical Pharmacology},
  doi = {10.1016/j.bcp.2026.118486},
  url = {https://doi.org/10.1016/j.bcp.2026.118486}
}

RIS

TY  - JOUR
TI  - AXL drives immunotherapy resistance by modulating IL-17 in bladder cancer
AU  - Wenlong Wan
AU  - Fang Wei
AU  - Lu Yang
AU  - Xiao Yu
AU  - Ziqi Wang
AU  - Jianping Miao
AU  - Ben Zhao
PY  - 2026
JO  - Biochemical Pharmacology
DO  - 10.1016/j.bcp.2026.118486
UR  - https://doi.org/10.1016/j.bcp.2026.118486
ER  -

APA

Wan, W., Wei, F., Yang, L., Yu, X., Wang, Z., Miao, J., & Zhao, B. (2026). AXL drives immunotherapy resistance by modulating IL-17 in bladder cancer. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118486

Source records

crossref · retrieved 2026-11-10T10:23:35.572Z